💨 Abstract

Neurogene Inc. reported a $22 million loss in the second quarter, amounting to a $1.05 loss per share. Although the company experienced a loss, it exceeded Wall Street expectations, which were for a loss of $1.15 per share.

Courtesy: WTOP Staff